It's always interesting when a drug for one disease is found to be useful for other diseases.
They aren't sure how this JAK inhibitors (baricitinib) helps with GVHD, but the article shares one theory: that it keeps donor T cells circulating in the bloodstream and away from vital organs.
__________________
Founder of Marrowforums and caregiver for my wife
|